Molecular Medicine

, Volume 16, Issue 9–10, pp 335–342 | Cite as

Peroxynitrite-induced Nitration of Cyclooxygenase-2 and Inducible Nitric Oxide Synthase Promotes Their Binding in Diabetic Angiopathy

  • Yanning Li
  • Jinsheng Qi
  • Kun Liu
  • Bin Li
  • Hui Wang
  • Jinhai Jia
Research Article


Cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) play crucial roles in diabetic angiopathy. In vivo, however, the following facts remain unknown: whether COX-2 and iNOS bind, how peroxynitrite-induced nitration of COX-2 and iNOS affects their binding if they do bind and what effects of this mechanism contribute to diabetic angiopathy. This study focused on the issues above. Diabetes was induced in Wistar male rats by intraperitoneal injection of streptozotocin. As a specific scavenger of peroxynitrite, urate was used. After 13 wks of diabetes, the morphological and biochemical changes of the rats showed obvious diabetic angiopathy. There exists in vivo colocalization and binding of COX-2 and iNOS in diabetic angiopathy. The nitration level of total and coimmunoprecipitated COX-2 and iNOS increased significantly, and, simultaneously, their binding and activity increased in the diabetes group. In the diabetes + urate group, the nitration level of COX-2 and iNOS decreased and their binding reduced, consistent with their decreased activity and the attenuated pathological changes in the rat aorta and glomerulus. The results provide in vivo evidence that COX-2 and iNOS can bind in diabetic angiopathy and that peroxynitrite-induced nitration of COX-2 and iNOS promotes their binding, contributing to diabetic angiopathy.



This study was supported by the Hebei Natural Science Foundation (C2009001092), the Bureau of Education of Hebei province (B2004122), the Bureau of Science and Technology of Hebei province (07276101D), the Bureau of Science and Technology of Shijiazhuang city (04146173A and 07120803a), the Bureau of Sanitation of Hebei province (04062) and Hebei Medical University (040028).


  1. 1.
    Rahman S, Rahman T, Ismail AA, Rashid AR. (2007) Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes. Metab. 9:767–80.CrossRefGoogle Scholar
  2. 2.
    Brown WV. (2008) Microvascular complications of diabetes mellitus: renal protection accompanies cardiovascular protection. Am. J. Cardiol. 102:10L–13L.CrossRefGoogle Scholar
  3. 3.
    Agrawal NK, Maiti R, Dash D, Pandey BL. (2007) Cilostazol reduces inflammatory burden and oxidative stress in hypertensive type 2 diabetes mellitus patients. Pharmacol. Res. 56:118–23.CrossRefGoogle Scholar
  4. 4.
    Loomans CJ, et al. (2009) Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia. Mol. Med. 15:152–9.CrossRefGoogle Scholar
  5. 5.
    Wenzel P, et al. (2008) Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis 198:65–76.CrossRefGoogle Scholar
  6. 6.
    Blanco M, Rodriguez-Yánez M, Sobrino T, Leira R, Castillo J. (2005) Platelets, inflammation, and atherothrombotic neurovascular disease: the role of endothelial dysfunction. Cerebrovasc. Dis. 20 Suppl 2:S32–9.CrossRefGoogle Scholar
  7. 7.
    Kiritoshi S, et al. (2003) Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 52:2570–7.CrossRefGoogle Scholar
  8. 8.
    Kim SF, Huri DA, Snyder SH. (2005) Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310:1966–70.CrossRefGoogle Scholar
  9. 9.
    Xu L, Han C, Lim K, Wu T. (2008) Activation of cytosolic phospholipase A2alpha through nitric oxide-induced S-nitrosylation: involvement of inducible nitric oxide synthase and cyclooxygenase-2. J. Biol. Chem. 283:3077–87.CrossRefGoogle Scholar
  10. 10.
    Qi JS, Li YN, Zhang BS, Niu T, Liang JH. (2008) Peroxynitrite mediates high glucose-induced osteoblast apoptosis. J. Endocrinol. Invest. 31:314–20.CrossRefGoogle Scholar
  11. 11.
    Ren XY, Li YN, Qi JS, Niu T. (2008) Peroxynitrite-induced protein nitration contributes to liver mitochondrial damage in diabetic rats. J. Diabetes Complications 22:357–64.CrossRefGoogle Scholar
  12. 12.
    Taguchi K, Kobayashi T, Hayashi Y, Matsumoto T, Kamata K. (2007) Enalapril improves impairment of SERCA-derived relaxation and enhancement of tyrosine nitration in diabetic rat aorta. Eur. J. Pharmacol. 556:121–8.CrossRefGoogle Scholar
  13. 13.
    Wu F, Wilson JX. (2009) Peroxynitrite-dependent activation of protein phosphatase type 2A mediates microvascular endothelial barrier dysfunction. Cardiovasc. Res. 81:38–45.CrossRefGoogle Scholar
  14. 14.
    Zou MH. (2007) Peroxynitrite and protein tyrosine nitration of prostacyclin synthase. Prostaglandins Other Lipid Mediat. 82:119–27.CrossRefGoogle Scholar
  15. 15.
    Robinson KM, Morré JT, Beckman JS. (2004) Triuret: a novel product of peroxynitrite-mediated oxidation of urate. Arch. Biochem. Biophys. 423:213–7.CrossRefGoogle Scholar
  16. 16.
    Demicheli V, Quijano C, Alvarez B, Radi R. (2007) Inactivation and nitration of human superoxide dismutase (SOD) by fluxes of nitric oxide and superoxide. Free Radic. Biol. Med. 42:1359–68.CrossRefGoogle Scholar
  17. 17.
    El-Remessy AB, et al. (2003) Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am. J. Pathol. 162:1995–2004.CrossRefGoogle Scholar
  18. 18.
    Garcia-Ruiz I, et al. (2006) Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice. Hepatology 44:581–91.CrossRefGoogle Scholar
  19. 19.
    Scott GS, Hooper DC. (2001) The role of uric acid in protection against peroxynitrite-mediated pathology. Med. Hypotheses 56:95–100.CrossRefGoogle Scholar
  20. 20.
    Cosentino F, et al. (2003) High glucose causes up-regulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 107:1017–23.CrossRefGoogle Scholar
  21. 21.
    Zhang M, et al. (2006) Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stress. Metabolism 55:1590–8.CrossRefGoogle Scholar
  22. 22.
    St-Onge M, et al. (2007) Characterization of prostaglandin E2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophils. Biochim. Biophys. Acta. 1771:1235–45.CrossRefGoogle Scholar
  23. 23.
    Sheu ML, et al. (2005) High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway. Arterioscler. Thromb. Vasc. Biol. 25:539–45.CrossRefGoogle Scholar
  24. 24.
    Shi Y, Vanhoutte PM. (2008) Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats. Br. J. Pharmacol. 154:639–51.CrossRefGoogle Scholar
  25. 25.
    Chen YJ, Quilley J. (2008) Fenofibrate treatment of diabetic rats reduces nitrosative stress, renal cyclooxygenase-2 expression, and enhanced renal prostaglandin release. J. Pharmacol. Exp. Ther. 324:658–63.CrossRefGoogle Scholar
  26. 26.
    Massi D, et al. (2009) Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis. Mod. Pathol. 22:21–30.CrossRefGoogle Scholar
  27. 27.
    Amore A, et al. (2004) Amadori-configurated albumin induces nitric oxide-dependent apoptosis of endothelial cells: a possible mechanism of diabetic vasculopathy. Nephrol. Dial. Transplant. 19:53–60.CrossRefGoogle Scholar
  28. 28.
    Zheng L, et al. (2007) Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 50:1987–96.CrossRefGoogle Scholar
  29. 29.
    Inagi R, et al. (2006) A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice. Diabetes 55:356–66.CrossRefGoogle Scholar
  30. 30.
    Pacher P, Szabo C. (2006) Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr. Opin. Pharmacol. 6:136–41.CrossRefGoogle Scholar
  31. 31.
    Vareniuk I, Pavlov IA, Obrosova IG. (2008) Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes. Diabetologia 51:2126–33.CrossRefGoogle Scholar
  32. 32.
    Obrosova IG, et al. (2007) Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. Am. J. Physiol. Endocrinol. Metab. 293:E1645–55.CrossRefGoogle Scholar
  33. 33.
    Pacher P, Beckman JS, Liaudet L. (2007) Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87:315–424.CrossRefGoogle Scholar
  34. 34.
    Rachek LI, Musiyenko SI, LeDoux SP, Wilson GL. (2007) Palmitate induced mitochondrial deoxyribonucleic acid damage and apoptosis in l6 rat skeletal muscle cells. Endocrinology 148:293–9.CrossRefGoogle Scholar
  35. 35.
    Xiao H, Li YN, Qi JS, Wang H, Liu K. (2009) Peroxynitrite plays a key role in glomerular lesion of diabetic rat. J. Nephrol. 22:800–8.PubMedGoogle Scholar
  36. 36.
    Beharka AA, Wu D, Serafini M, Meydani SN. (2002) Mechanism of vitamin E inhibition of cyclooxygenase activity in macrophages from old mice: role of peroxynitrite. Free Radic. Biol. Med. 32:503–11.CrossRefGoogle Scholar
  37. 37.
    Cooke CL, Davidge ST. (2002) Peroxynitrite increases iNOS through NF-kappa B and decreases prostacyclin synthase in endothelial cells. Am. J. Physiol. Cell Physiol. 282:C395–402.CrossRefGoogle Scholar

Copyright information

© The Feinstein Institute for Medical Research 2010

Authors and Affiliations

  • Yanning Li
    • 1
  • Jinsheng Qi
    • 2
  • Kun Liu
    • 2
  • Bin Li
    • 2
  • Hui Wang
    • 3
  • Jinhai Jia
    • 2
  1. 1.Department of Molecular BiologyHebei Key Lab of Laboratory AnimalShijiazhuang, PRChina
  2. 2.Department of BiochemistryHebei Medical UniversityShijiazhuangChina
  3. 3.Department of PathologyHebei Medical UniversityShijiazhuang, PRChina

Personalised recommendations